Enhancing primary prevention: the incremental predictive value of high-sensitivity cardiac troponin T beyond ASCVD risk assessment

Andraz, S.Pereira, J. MassaCosta, H.Espirito Santo, M.Hamann, L.Fernandes, R.Bispo, J.Carvalho, D.Bento, D.Azevedo, P.Mimoso, J.2024-11-262024-11-262024-100195-668Xhttp://hdl.handle.net/10400.1/26337Atherosclerotic cardiovascular disease (ASCVD) is a global health challenge, prompting widespread use of conventional risk assessment tools (SCORE2 in Europe and the ASCVD Risk calculator in the United States) to guide preventive strategies. Emerging evidence indicates that high-sensitivity cardiac troponin (hsTn) may refine risk stratification.engEnhancing primary prevention: the incremental predictive value of high-sensitivity cardiac troponin T beyond ASCVD risk assessmentconference object10.1093/eurheartj/ehae666.27311522-9645